NCT06586021NARecruiting
Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall
Endoron Medical
Start Date
2/6/2024
Completion Date
11/1/2029
Summary
The Aortoseal Endostapling System is indicated in patients undergoing, or having undergone, treatment of an abdominal aortic aneurysm (AAA) with an endovascular graft to provide enhanced fixation and apposition to the aorta.
Detailed Description
The device may be implanted at the time of the initial endovascular graft procedure to maintain, or during a secondary procedure to restore, adequate aneurysm. The study includes 5 years of follow-up, with visits at 30 days, 6 months, 1 year, and yearly thereafter through 5-years. Follow-up assessments: Physical examination, X-ray, CT (with and without contrast) and assessments of any adverse events.
Eligibility Criteria
Age Range: 18 years to No maximum
Subjects diagnosed with a qualifying AAA suitable for elective endovascular repair with Endovascular Graft System or have a previously placed endovascular graft.
Interventions
DEVICE
Aortoseal Endostapling System
Conditions
Abdominal Aortic Aneurysm (AAA)
Locations
Sentara Health Research Center
Norfolk, Virginia 23507
United States